home / stock / anix / anix news


ANIX News and Press, Anixa Biosciences Inc. From 12/02/19

Stock Information

Company Name: Anixa Biosciences Inc.
Stock Symbol: ANIX
Market: NASDAQ
Website: anixa.com

Menu

ANIX ANIX Quote ANIX Short ANIX News ANIX Articles ANIX Message Board
Get ANIX Alerts

News, Short Squeeze, Breakout and More Instantly...

ANIX - Anixa Biosciences Announces Presentation at the 2019 San Antonio Breast Cancer Symposium

SAN JOSE, Calif. , Dec. 2, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data from its ongoing studies utilizing Cchek™, its artificial int...

ANIX - Anixa Biosciences Announces Genesis Research to Join Cchek(TM) Prostate Cancer Study

SAN JOSE, Calif. , Nov. 26, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced the addition of Genesis Research, LLC to the ongoing Cchek™ prostate c...

ANIX - Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek(TM) Prostate Cancer Study

SAN JOSE, Calif. , Nov. 22, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced a collaboration with Urology Centers of Alabama (UCA) in the Cchek™ ...

ANIX - Anixa Biosciences Announces Collaboration with Idaho Urologic Institute on Cchek(TM) Prostate Cancer Study

SAN JOSE, Calif. , Nov. 20, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced its collaboration with Idaho Urologic Institute, PA (IUI) in the Cchek™...

ANIX - Anixa Biosciences Announces Presentation at Cell Symposia: Hallmarks of Cancer

SAN JOSE, Calif. , Nov. 7, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data from its ongoing studies utilizing Cchek™, its artificial intellig...

ANIX - Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine

SAN JOSE, Calif. , Nov. 5, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that the United States Patent and Trademark Office (USPTO) has issued US Paten...

ANIX - Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board

SAN JOSE, Calif. , Oct. 28, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced the appointment of Emanuele Ostuni , Ph.D. to its Scientific Advisory Board....

ANIX - Anixa Bio teams up Urology San Antonio for Cchek prostate cancer study

Anixa Biosciences (NASDAQ: ANIX ) has collaborated with Urology San Antonio, PA in its ongoing Cchek prostate cancer study. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Read more ...

ANIX - Anixa Biosciences Announces Collaboration with Urology San Antonio on Cchek(TM) Prostate Cancer Study

SAN JOSE, Calif. , Oct. 25, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced its collaboration with Urology San Antonio, PA in Anixa's ongoing CchekȒ...

ANIX - Anixa Biosciences Announces Abstract Accepted for Presentation at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2019)

SAN JOSE, Calif. , Oct. 22, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced the acceptance of an abstract at the 34 th Annual Meeting of the Society for Immunothera...

Previous 10 Next 10